Literature DB >> 26843507

Rituximab improved systemic lupus erythematosus-associated pulmonary alveolar proteinosis without decreasing anti-GM-CSF antibody levels.

J Nagasawa1, K Kurasawa2, R Hanaoka3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26843507     DOI： 10.1177/0961203315627204

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  1 in total

1.  Rituximab for auto-immune alveolar proteinosis, a real life cohort study.

Authors:  Berenice Soyez; Raphael Borie; Cedric Menard; Jacques Cadranel; Leonidas Chavez; Vincent Cottin; Emmanuel Gomez; Sylvain Marchand-Adam; Sylvie Leroy; Jean-Marc Naccache; Hilario Nunes; Martine Reynaud-Gaubert; Laurent Savale; Abdellatif Tazi; Lidwine Wemeau-Stervinou; Marie-Pierre Debray; Bruno Crestani
Journal:  Respir Res       Date:  2018-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.